sample_id	patient_cohort	age	sex	diagnosis	stage	plasma_CA19_9	creatinine	LYVE1	REG1B	TFF1	REG1A	sampling_country	cutoff_plasma
1	Cohort_1	33	Female	control	NA	11.7	1.83222	-1.0635990171459035	-0.08863372301146955	-0.17013881815938348	1.5349280217835126	United Kingdom	0
116	Cohort_1	28	Female	control	NA	8.7	0.50895	-1.4902272083355266	-1.4464896051721197	-1.065704274299713	0.3372743538090557	United Kingdom	0
118	Cohort_1	50	Female	control	NA	8.7	0.95004	-6.5233878615174135	-0.025506101313613527	-1.3948347277019995	-0.6855440954895204	United Kingdom	0
123	Cohort_1	45	Male	control	NA	9.6	1.3572	-0.07818477876107488	-0.7077300636686235	-0.785350991107653	0.7277546068220451	United Kingdom	0
124	Cohort_1	35	Male	control	NA	4	0.24882	-7.863162207002412	-1.8338590670294543	-4.856814272592589	0.8306253470517824	United Kingdom	0
125	Cohort_1	30	Male	control	NA	10.8	1.18755	-0.4804765185307123	-0.9457217934409838	-0.9528381873762015	0.7401113395109506	United Kingdom	0
27	Cohort_1	44	Female	control	NA	8.47	0.18096	-5.37948293312602	-3.294328800790135	-10.914203254187504	-2.994279449486627	United Kingdom	0
30	Cohort_1	58	Female	control	NA	13.58	0.57681	-1.0965717308028868	-0.9866059878035376	-9.754966343702959	-1.4172045023043562	United Kingdom	0
33	Cohort_1	50	Male	control	NA	3.53	0.57681	-1.5748694234919918	-1.1713936947830756	-1.715654117662945	-1.2035732178364942	United Kingdom	0
37	Cohort_1	58	Male	control	NA	5.8	2.27331	0.6294558946577503	0.36546357658593376	-0.5358471129088542	-0.13215411279044176	United Kingdom	0
41	Cohort_1	46	Male	control	NA	3.59	0.13572	-8.469298010572727	-2.1455063643429635	-2.3159768157557936	-2.551335178192086	United Kingdom	0
42	Cohort_1	62	Male	control	NA	7.55	1.11969	-3.401911794421896	-2.8061116227920775	-0.9019530760576409	-2.2968450561893987	United Kingdom	0
45	Cohort_1	52	Male	control	NA	5.7	1.05183	0.5834604282360455	-0.0511903154721951	-1.8407742920285735	-0.19095467794535903	United Kingdom	0
46	Cohort_1	57	Female	control	NA	37.03	0.49764	-0.9513046513590909	-2.9268123243917037	-2.64184264159595	-2.7783297495869923	United Kingdom	1
48	Cohort_1	40	Male	control	NA	12.84	0.42978	-0.8960228092065652	-3.4548782885820026	-3.1539546938257956	-1.4338953963860028	United Kingdom	0
53	Cohort_1	54	Male	control	NA	6.77	0.95004	0.5789675869946044	-0.0511903154721951	-2.037032932923208	-0.4512974487990169	United Kingdom	0
54	Cohort_1	62	Male	control	NA	10.43	1.93401	1.0051203677575007	1.5818658702121127	0.608601081595169	1.101009633241346	United Kingdom	0
55	Cohort_1	61	Male	control	NA	7.57	1.40244	-0.5897158034719432	0.583037568252462	0.08615955617260518	0.023131527348152048	United Kingdom	0
56	Cohort_1	67	Female	control	NA	31.24	0.9048	0.4127923084879742	-1.2932889910357077	-2.117316844736763	-1.5895204505467966	United Kingdom	0
57	Cohort_1	40	Female	control	NA	28.18	1.74174	1.1562951050799297	0.47486667678583494	-0.8786500160731396	0.2389551896060551	United Kingdom	0
58	Cohort_1	56	Female	control	NA	18.23	0.87087	0.3463990670137064	-0.8481619420403561	-0.8442514319468772	-1.218684989648235	United Kingdom	0
76	Cohort_1	30	Female	control	NA	0.6	0.87087	-0.7900588819121298	-0.9330077399339549	-2.170638983914732	0.8714473415720372	United Kingdom	0
77	Cohort_1	41	Female	control	NA	16.4	2.00187	-2.7982763165244444	-3.4872427480804493	-1.5173565759453895	-0.905044655525229	United Kingdom	0
338	Cohort_1	52	Male	benign	NA	31.62	0.375492	0.36075496525969564	1.3153694925742672	-0.16630954846392765	1.568550532946225	United Kingdom	0
368	Cohort_1	68	Female	benign	NA	23.17	0.629967	0.1946502591686522	-0.27893209832359167	-1.9070008860009864	-0.08875107014357653	United Kingdom	0
369	Cohort_1	53	Male	benign	NA	68.72	0.409422	-0.07525243398850745	0.8628500378198378	-2.6330692535289346	1.2329337686618347	United Kingdom	1
184	Cohort_1	39	Female	benign	NA	18	0.80301	-0.745254722549898	-2.092082418687724	-1.2138580022956198	-1.9671234046929462	United Kingdom	0
185	Cohort_1	38	Female	benign	NA	26	2.29593	-5.6409986813189406	-2.377841429694149	-0.6754160158130649	-1.7770575529966557	United Kingdom	0
188	Cohort_1	59	Male	benign	NA	323	2.18283	1.2457106947821392	1.209812185524747	0.7747540497915582	1.9237310492719217	United Kingdom	1
189	Cohort_1	44	Male	benign	NA	2	0.66729	0.7464898458347088	-1.7796116483291136	-1.1749633797830477	-2.239713050326286	United Kingdom	0
190	Cohort_1	67	Male	benign	NA	73	1.17624	-0.08612852274870675	-1.8432493073857468	1.7496040169440006	2.066137813422663	United Kingdom	1
192	Cohort_1	37	Female	benign	NA	6	0.72384	-1.1916096183172504	-2.377841429694149	-1.4198144267537351	-2.517259146360722	United Kingdom	0
194	Cohort_1	38	Male	benign	NA	10	1.30065	-0.023790541989879288	-3.3259294544254567	-0.6646720090879086	-0.7599687938203887	United Kingdom	0
195	Cohort_1	71	Male	benign	NA	22	0.89349	0.16974792771282055	0.3497460680705089	0.051844294442149774	-0.8079014460030427	United Kingdom	0
198	Cohort_1	39	Female	benign	NA	12	0.18096	0.5400723121044743	-0.6688810731437043	-0.5866098129637729	0.8391132610365979	United Kingdom	0
199	Cohort_1	48	Female	benign	NA	50	0.65598	0.090314131204143	0.48652928772277626	-0.5865836203570174	-1.0672534726849987	United Kingdom	1
200	Cohort_1	66	Male	benign	NA	1541	1.30065	-0.7572148042345694	-1.3054395064642952	0.4592487520931048	-1.3879751137300937	United Kingdom	1
201	Cohort_1	51	Female	benign	NA	35	0.63336	-1.5270366618180973	-0.5409356933092839	-0.787309200033258	-1.2686526686508737	United Kingdom	0
203	Cohort_1	50	Male	benign	NA	24	0.50895	0.4489264145041941	-1.0733920043305147	1.0454997052897692	0.461531574728558	United Kingdom	0
204	Cohort_1	70	Female	benign	NA	29	2.32986	1.070240352011019	0.9663250911568833	0.005847255186193223	0.6466331647706296	United Kingdom	0
206	Cohort_1	68	Female	benign	NA	28	0.62205	-2.130130269516596	-2.245629360662718	-0.9439295563472099	-1.693362025688585	United Kingdom	0
207	Cohort_1	64	Male	benign	NA	263	0.52026	0.8984412021999234	0.7455204374410416	0.6818984919033415	1.0005412106286853	United Kingdom	1
209	Cohort_1	60	Female	benign	NA	9	1.32327	-1.662635791484484	-1.4584602476673627	-0.49351231756877745	-1.315791871252042	United Kingdom	0
210	Cohort_1	67	Male	benign	NA	1913	1.07445	0.43629038178462165	0.15512027890430513	-0.17446875196749456	-0.1111475718651409	United Kingdom	1
211	Cohort_1	44	Male	benign	NA	4	0.57681	-1.423855621800577	-1.5800521730794204	-0.9161689021070076	-1.1200058646001532	United Kingdom	0
212	Cohort_1	53	Female	benign	NA	11	0.97266	0.806202546308289	-0.28417131654028926	-0.47910320044766674	-0.7956278323629293	United Kingdom	0
213	Cohort_1	49	Female	benign	NA	1	0.72384	-0.5194168508515636	-3.412737575444707	-1.2288839176942528	-1.1274952651608068	United Kingdom	0
214	Cohort_1	72	Male	benign	NA	72	1.05183	0.9916808031602106	1.0474212455129068	0.3060552039941795	0.9238456406016367	United Kingdom	1
215	Cohort_1	57	Female	benign	NA	32	0.92742	-2.6145778244511915	-1.7116125825231125	-4.249594175519096	-1.0438992823629185	United Kingdom	0
216	Cohort_1	66	Male	benign	NA	86	1.87746	0.702636641723252	-0.17952173203767918	0.43820566803082794	-0.7569225004024958	United Kingdom	1
217	Cohort_1	47	Male	benign	NA	21	2.02449	0.7667850072922618	-0.7228942241885266	0.2368413468175854	-0.7229958632008477	United Kingdom	0
218	Cohort_1	70	Male	benign	NA	64	0.46371	0.33746483850099585	2.0699011627719717	-0.07863935229381624	-1.1249887849976972	United Kingdom	1
219	Cohort_1	40	Female	benign	NA	13	0.61074	-1.9216748150325604	-3.966749007305661	-1.1880938758179616	-2.746758602836812	United Kingdom	0
220	Cohort_1	53	Female	benign	NA	5	1.37982	-0.1995247944437898	-1.8838613336879995	-1.1179413949802992	-1.1175293061990574	United Kingdom	0
221	Cohort_1	73	Male	benign	NA	107	0.64467	1.1896408490776125	1.3722786542337362	0.6177193142459121	1.6843080009756433	United Kingdom	1
222	Cohort_1	44	Male	benign	NA	20	2.79357	0.4026697053334164	-0.5194078933996154	0.14538746831943516	-0.7836882141151262	United Kingdom	0
356	Cohort_1	64	Female	benign	NA	11.04	0.640146	-0.9303036806700259	-0.6872555969171579	-0.7112572346182491	0.5643513662609418	United Kingdom	0
233	Cohort_1	46	Male	benign	NA	114.8	1.40244	-0.43840377635210637	-1.6116763493236186	-0.2788711379421285	-0.6855440954895204	United Kingdom	1
349	Cohort_1	41	Male	benign	NA	14	2.326467	1.070918960822806	-0.746269102250122	-0.2886049558645958	-0.20538238072103532	United Kingdom	0
249	Cohort_1	51	Male	benign	NA	19	0.5655	0.6972833965979272	-0.11059392757536024	-0.14075643946762284	1.9644026339250065	United Kingdom	0
244	Cohort_1	67	Male	benign	NA	15.2	0.38454	0.3690778164661691	0.510183281564081	-0.980564771363051	2.0949965032531495	United Kingdom	0
286	Cohort_1	56	Male	benign	NA	10.9	1.42506	0.055010610622199585	1.4836107478972913	0.1559236437872089	0.6878942575288356	United Kingdom	0
307	Cohort_1	67	Female	benign	NA	6.9	0.95004	-1.8764616724653997	-1.2763033398962969	-1.9206428582668726	0.20561597165905532	United Kingdom	0
366	Cohort_1	54	Female	benign	NA	6.8	0.368706	-1.4580277507762744	-0.5685187495096584	-1.1465766265874935	-0.5188859342245618	United Kingdom	0
367	Cohort_1	46	Male	benign	NA	190.7	1.421667	1.080558778798137	1.277301419769186	0.4921243736117278	1.4425555196062554	United Kingdom	1
294	Cohort_1	40	Male	benign	NA	7.9	1.00659	-0.5020170654494529	0.7962568906454672	-0.8276502896253595	2.739930406844283	United Kingdom	0
239	Cohort_1	29	Male	benign	NA	32.3	0.46371	0.442370263662632	-0.5300174528576536	-0.921299812419651	1.0460468522720818	United Kingdom	0
254	Cohort_1	74	Female	benign	NA	16.2	1.93401	0.24142991392917568	0.42429119593225284	0.48496942379100805	2.492813824871411	United Kingdom	0
337	Cohort_1	55	Male	benign	NA	6.71	0.390195	-7.413245336323413	-3.708946125475004	-3.0080875079206955	-2.331895894796674	United Kingdom	0
456	Cohort_1	57	Male	malignant	IA	10	1.73043	0.01570905384184884	-0.35367919354644917	-0.3808307178693964	-0.5603594843245672	United Kingdom	0
520	Cohort_1	55	Male	malignant	IA	11	0.47502	0.08979210581860586	-0.5492198725900312	-0.875481181431705	-0.25753692603002776	United Kingdom	0
401	Cohort_1	73	Male	malignant	IB	3236	0.70122	1.5545089006262445	1.2248469606017292	0.6788114306450002	0.46502100239851174	United Kingdom	1
410	Cohort_1	75	Male	malignant	IB	255	0.91611	-0.00780307314850337	-1.3045703582684558	-0.9599125896086758	-1.0185188059572257	United Kingdom	1
482	Cohort_1	68	Female	malignant	IB	39	0.57681	-0.5979948753772677	-2.0999599720742683	-9.754966343702959	-1.9188730461940606	United Kingdom	1
531	Cohort_1	77	Female	malignant	IB	55.6	0.57681	-0.21757015133582536	-0.9558785868855129	-2.649900841418251	1.4728165582400257	United Kingdom	1
534	Cohort_1	56	Male	malignant	IB	0.6	0.96135	1.1494937223971071	2.224833076200871	0.34895055514695983	3.2903180077045695	United Kingdom	0
419	Cohort_1	68	Male	malignant	IIA	147	0.49764	0.8201594895307099	1.5483251505226914	1.2690198035229763	1.424755807579146	United Kingdom	1
426	Cohort_1	67	Male	malignant	IIA	1624	0.21489	0.7830986071847547	-0.6319190101809764	-0.6704206160376565	-0.6717707715573473	United Kingdom	1
427	Cohort_1	75	Female	malignant	IIA	279	0.40716	-0.4069402497464293	-0.3409769370206659	-0.6425355089032356	-0.6703319223882485	United Kingdom	1
437	Cohort_1	64	Female	malignant	IIA	309	0.58812	-0.7405752948440182	0.9151487405424428	0.8435378309843733	0.3453414645284907	United Kingdom	1
438	Cohort_1	64	Female	malignant	IIA	1972	0.83694	-0.6093176153609994	-1.4465194167781914	-0.5858865024909221	-2.282757759359306	United Kingdom	1
441	Cohort_1	55	Male	malignant	IIA	1004	1.0179	1.221456859148876	0.9539233610515323	0.303248359299638	0.5321480356304242	United Kingdom	1
444	Cohort_1	56	Female	malignant	IIA	7	1.06314	-1.4741159408480815	-0.6662711700990456	-0.08708766725401507	-1.2307370224674656	United Kingdom	0
451	Cohort_1	72	Male	malignant	IIA	328	1.00659	0.27371243138249535	1.4292376478573479	1.1415524657555078	1.1708690798479013	United Kingdom	1
530	Cohort_1	73	Female	malignant	IIA	354	0.15834	-2.3686259141682746	-0.5031441103650347	-3.7716157654469016	2.2137094325414246	United Kingdom	1
394	Cohort_1	73	Male	malignant	IIB	538	0.76908	-0.011258122073694588	-1.3382137511448122	-2.0355117619235212	-1.5506492030059116	United Kingdom	1
396	Cohort_1	62	Female	malignant	IIB	1098	1.17624	1.198372770917406	0.6948999508976987	1.1871518105692207	0.5458493044124078	United Kingdom	1
399	Cohort_1	69	Male	malignant	IIB	31000	0.13572	1.1017466618348557	1.3463653702541327	0.68693016020001	0.7452402692979954	United Kingdom	1
403	Cohort_1	66	Male	malignant	IIB	601	0.85956	1.5738433594758634	1.7973085198369354	1.4075904861946844	2.3638766491700123	United Kingdom	1
404	Cohort_1	74	Female	malignant	IIB	554	0.55419	8.562454190720326e-4	0.4238430753787439	-1.2416343060609645	-0.06834037179045982	United Kingdom	1
407	Cohort_1	77	Male	malignant	IIB	33	0.54288	0.4771400373338385	-1.3730285461791438	-0.9940641330043869	-2.259875586288302	United Kingdom	0
411	Cohort_1	77	Male	malignant	IIB	42	0.72384	1.1125074597842302	1.774742019496233	1.0245932222720544	-1.7201335068904169	United Kingdom	1
413	Cohort_1	61	Male	malignant	IIB	155	0.84825	0.5537338101805408	0.8521010487614538	0.3555419485893987	0.17639064674189786	United Kingdom	1
414	Cohort_1	58	Female	malignant	IIB	66	0.62205	0.39209322250260914	0.4697680817464338	-0.6633029559717905	0.14277501084630462	United Kingdom	1
415	Cohort_1	69	Female	malignant	IIB	138	0.37323	0.42349263412765603	-0.36654505004712323	-0.10490640640268722	-1.1090765490455023	United Kingdom	1
416	Cohort_1	61	Female	malignant	IIB	476	1.131	0.9361694762685261	0.4355233689035245	-0.8083273493419085	0.1952329124619414	United Kingdom	1
418	Cohort_1	77	Male	malignant	IIB	68	1.22148	0.7956054111474792	1.5254801040473867	1.3232905724324118	1.4752192344246104	United Kingdom	1
420	Cohort_1	62	Male	malignant	IIB	143	0.4524	0.4105292349363264	1.2762420567019532	-1.5522475840549648	0.9592665972679733	United Kingdom	1
421	Cohort_1	45	Female	malignant	IIB	941	0.47502	-0.6093176153609994	1.6274719733192295	-0.8639439120617141	1.4316686604223197	United Kingdom	1
422	Cohort_1	67	Female	malignant	IIB	74	0.66729	1.2387045823632383	1.867666494439626	1.386518348030271	1.6792314172932699	United Kingdom	1
423	Cohort_1	68	Male	malignant	IIB	91	2.30724	0.8773945902860584	0.09258862223365849	-0.2851585000529573	-1.2419806360226495	United Kingdom	1
425	Cohort_1	71	Male	malignant	IIB	35	2.19414	0.6567846047179807	0.4238430753787439	0.2682681814935268	-0.506933796463156	United Kingdom	0
429	Cohort_1	75	Female	malignant	IIB	600	0.31668	0.7238442196827989	1.3785354721261305	0.6369616037197483	0.7335035914369881	United Kingdom	1
431	Cohort_1	63	Female	malignant	IIB	1510	0.64467	1.1872432828942796	1.0804172220559556	0.2682681814935268	0.5971724260787115	United Kingdom	1
432	Cohort_1	71	Male	malignant	IIB	1465	0.50895	0.3290070317905657	1.8814365652813096	1.1768017066980834	2.0506120304835616	United Kingdom	1
433	Cohort_1	73	Male	malignant	IIB	1503	0.99528	0.9080075146825676	0.17122908218970867	-0.3039217760992452	-0.2025774056915255	United Kingdom	1
440	Cohort_1	54	Female	malignant	IIB	110	0.55419	0.9346256663253584	0.828864615609791	0.04497022478913859	0.3047511621034955	United Kingdom	1
442	Cohort_1	59	Female	malignant	IIB	231	1.30065	-0.8540346417414173	-1.0439365204578182	-0.658530028601982	-1.2782450053188663	United Kingdom	1
443	Cohort_1	61	Female	malignant	IIB	64	0.07917	-0.4430452287749228	-1.5258432100491177	-0.7021330458102888	-1.615153049478523	United Kingdom	1
447	Cohort_1	74	Female	malignant	IIB	100	0.18096	0.7956054111474792	1.061968041472067	0.29081094247772477	0.5610560216935472	United Kingdom	1
448	Cohort_1	73	Female	malignant	IIB	182	0.40716	0.806202546308289	1.9307978245738457	0.7225473218923746	2.062050086741327	United Kingdom	1
449	Cohort_1	78	Female	malignant	IIB	345	0.46371	0.9032357976894411	0.27868541646561606	0.29821366509541747	-0.07047682994688298	United Kingdom	1
450	Cohort_1	70	Male	malignant	IIB	1806	0.26013	0.5354768382896841	1.0971377053994855	-0.002053595862890667	0.49714766074743366	United Kingdom	1
452	Cohort_1	82	Female	malignant	IIB	22	0.36192	0.7576057251884937	1.0660866600639523	0.018508563008904133	1.0710444539570458	United Kingdom	0
453	Cohort_1	58	Male	malignant	IIB	134	0.91611	0.8558956420501068	1.8110016022949242	0.4879827027976402	1.4268670856684915	United Kingdom	1
454	Cohort_1	62	Male	malignant	IIB	62	0.53157	0.3346534182029698	-1.4505689737293648	-4.898098073507333	-1.5996110244749717	United Kingdom	1
455	Cohort_1	76	Female	malignant	IIB	30	0.2262	0.7758811517963623	1.9501912608034049	0.1461683691275555	1.6464779015932427	United Kingdom	0
461	Cohort_1	79	Female	malignant	IIB	1636	0.26013	0.22779091727284617	-1.147344640754711	-1.715654117662945	-1.2574689062149176	United Kingdom	1
465	Cohort_1	68	Male	malignant	IIB	1475	0.27144	1.0032885874371842	1.9069413585111192	0.7440350697142071	1.5763102396979871	United Kingdom	1
466	Cohort_1	70	Male	malignant	IIB	285	0.23751	1.0047300260153569	-0.6054221990810982	-1.2981840083834495	-0.36798791369687045	United Kingdom	1
471	Cohort_1	62	Female	malignant	IIB	318	1.36851	0.15973795683094483	1.0666457908733786	0.19343799008308604	0.2058225371492819	United Kingdom	1
472	Cohort_1	73	Male	malignant	IIB	275	0.46371	0.7502010365831066	0.5945594250020738	-0.3492666659364181	1.1772383000574376	United Kingdom	1
473	Cohort_1	72	Male	malignant	IIB	4115	0.59943	1.0303287497003653	2.1741460667655232	0.12014871660230142	2.1154015164236313	United Kingdom	1
475	Cohort_1	79	Male	malignant	IIB	737	1.08576	0.08309930260972764	1.1177156084885365	0.5451257689729045	0.09281265730259847	United Kingdom	1
477	Cohort_1	78	Male	malignant	IIB	457	1.28934	0.4183274737374839	-1.5762148970197347	-1.1798429590920243	2.007711559254192	United Kingdom	1
485	Cohort_1	59	Male	malignant	IIB	248.8	0.31668	-0.5414311302442012	-2.7074445288786397	-10.354587466252081	-0.8302408216433443	United Kingdom	1
489	Cohort_1	66	Male	malignant	IIB	36.27	1.22148	1.354170780363309	1.8489272274023403	0.23598353031487562	1.5726435798405234	United Kingdom	0
490	Cohort_1	80	Male	malignant	IIB	167.5	0.82563	0.8645873289115725	0.2785239921006255	-0.14200808815829724	0.33003826258175994	United Kingdom	1
525	Cohort_1	63	Male	malignant	IIB	523	0.31668	-7.6220001501855235	-3.4872427480804493	-10.354587466252081	-0.8959948200053116	United Kingdom	1
537	Cohort_1	44	Male	malignant	IIB	158	1.73043	-0.18833278885232618	0.7169902033284972	-1.5115574514234966	2.2504071784009687	United Kingdom	1
541	Cohort_1	60	Female	malignant	IIB	1749	0.38454	0.7735619044138832	0.867614635170165	0.8025930549681357	0.14067816922250742	United Kingdom	1
547	Cohort_1	67	Male	malignant	IIB	15	0.32799	0.6995063262815381	0.3255603188813181	-0.15600757465958637	2.6830094380962715	United Kingdom	0
557	Cohort_1	52	Female	malignant	IIB	41	0.23751	0.5427104734809814	-1.4623702365021507	-4.522726672548686	0.9355049778722577	United Kingdom	1
564	Cohort_1	61	Male	malignant	IIB	6.9	1.90008	0.5440946897115241	1.0409131813936998	0.05458479886317669	0.7462468645877918	United Kingdom	0
567	Cohort_1	66	Male	malignant	IIB	11740	0.73515	0.21050874924631946	-1.6825003326725958	-1.019971375967624	-1.5540879601068216	United Kingdom	1
392	Cohort_1	72	Male	malignant	III	509	0.54288	1.3877097869807127	0.11035535425922482	-0.7607870448578922	-0.27332810333593116	United Kingdom	1
393	Cohort_1	66	Female	malignant	III	537	0.97266	1.6683093266156597	2.309258991568086	1.3831843192390343	2.627081302554113	United Kingdom	1
395	Cohort_1	55	Male	malignant	III	181	0.50895	-0.1505238598605405	-0.8726901957378814	-0.7792550796459832	-1.1908980979102566	United Kingdom	1
397	Cohort_1	65	Female	malignant	III	216	1.21017	0.7540779749418046	-2.0239454587497363	-0.6318976779806595	-1.5429463618591956	United Kingdom	1
398	Cohort_1	72	Female	malignant	III	655	0.32799	1.251473455540311	1.3161711957332356	-0.22373171189179342	0.534475903447408	United Kingdom	1
400	Cohort_1	76	Male	malignant	III	1621	3.52872	2.222797727903328	-0.9156784524517305	1.5226360583110052	-0.9312766341499508	United Kingdom	1
402	Cohort_1	60	Male	malignant	III	859	0.74646	-2.1013362531567177	0.1285757984953353	0.43180204931124155	-0.1255279705984842	United Kingdom	1
405	Cohort_1	57	Male	malignant	III	244	2.97453	1.4065840602651933	-1.9288244233555676	-0.07801067132230965	-2.189931759371758	United Kingdom	1
406	Cohort_1	65	Female	malignant	III	1471	0.41847	1.092358643084443	0.5416421250838477	0.43959808226691877	-0.10269661560340104	United Kingdom	1
408	Cohort_1	78	Female	malignant	III	8634	0.83694	1.6154260164576426	1.9685379640842386	1.4397133581211916	1.788767697047997	United Kingdom	1
409	Cohort_1	69	Female	malignant	III	556	0.91611	1.0634716481566087	0.29000867476971326	0.6070062845276913	1.5116261413597378	United Kingdom	1
412	Cohort_1	68	Female	malignant	III	295	0.99528	0.7181048298465361	-0.3454323660023322	1.060846841571748	-0.4592813264058453	United Kingdom	1
417	Cohort_1	58	Male	malignant	III	1075	0.54288	-0.1899643215892317	1.4080266707889377	-0.8320489276994625	-1.2489572302141303	United Kingdom	1
424	Cohort_1	68	Male	malignant	III	103	0.2262	1.4004480433342144	0.6266796727475361	-0.530840048332232	0.35358160968221064	United Kingdom	1
428	Cohort_1	70	Male	malignant	III	291	1.75305	0.804444108508323	-0.4709577445310962	-0.018426365675807688	-0.6700947111289457	United Kingdom	1
430	Cohort_1	62	Male	malignant	III	60	1.49292	0.6278092211929415	2.123172954717594	0.13797619355565782	1.8813517100394819	United Kingdom	1
434	Cohort_1	51	Male	malignant	III	1120	0.32799	0.6849440033868511	-0.06594499401020304	-0.22609971799281858	-0.006651312521725572	United Kingdom	1
435	Cohort_1	69	Female	malignant	III	8978	1.21017	1.622970293135218	2.81641568652042	1.483081249800688	2.0787378669391883	United Kingdom	1
436	Cohort_1	67	Male	malignant	III	755	0.37323	1.318641862468143	1.8535318537988843	1.25447183838771	1.8008760069911105	United Kingdom	1
439	Cohort_1	67	Female	malignant	III	1990	1.66257	1.53963543196082	2.7875153847876053	2.051679612825626	2.4297888633087057	United Kingdom	1
445	Cohort_1	50	Male	malignant	III	129	0.42978	-0.5737774866006277	0.07327464509791781	-0.6775786882045631	-0.2822906771070599	United Kingdom	1
446	Cohort_1	77	Female	malignant	III	9250	0.21489	-0.412868042575531	-1.0357577034955936	-1.203859568695525	-1.5767862161935389	United Kingdom	1
457	Cohort_1	83	Male	malignant	III	43	0.4524	0.8114592111837983	-1.1089033749009753	-0.6797463023087884	-0.8823673761246438	United Kingdom	1
458	Cohort_1	59	Male	malignant	III	553	0.47502	0.17965869131941437	0.6131787344511599	-0.24778417437976152	0.47008764088846977	United Kingdom	1
459	Cohort_1	76	Female	malignant	III	120	2.25069	0.4311910703827305	0.20778767389007324	-0.3930818629454862	0.06600970578843501	United Kingdom	1
460	Cohort_1	56	Male	malignant	III	1	3.21204	0.5492006089095672	0.4918370081549188	0.24749613233595102	0.3303316739135074	United Kingdom	0
462	Cohort_1	39	Male	malignant	III	523	2.31855	-0.46785955702165966	-1.4370838401302666	-0.9439295563472099	-0.2990807675580003	United Kingdom	1
463	Cohort_1	63	Male	malignant	III	49	1.02921	1.2973689895050562	-0.9838385187494043	0.24491731479363743	-0.8264267386079291	United Kingdom	1
464	Cohort_1	39	Male	malignant	III	299	2.04711	0.35967556799982414	0.5390822554007695	-0.07131990319333958	0.651857085206041	United Kingdom	1
467	Cohort_1	70	Male	malignant	III	2114	1.56078	0.89908749422432	2.61164891971971	1.420530907229847	2.599193826757383	United Kingdom	1
468	Cohort_1	68	Male	malignant	III	1435	0.97266	1.1518176651112633	0.3989599111248916	0.11431693132570864	0.3140782586729136	United Kingdom	1
469	Cohort_1	78	Male	malignant	III	30	1.28934	1.0387179875926855	-0.31963115300707123	-0.22549520579115878	-0.5310827235775113	United Kingdom	0
470	Cohort_1	73	Female	malignant	III	551	0.82563	0.7938283979344786	0.074288238904888	-0.7705373360897649	-0.25114400663367853	United Kingdom	1
474	Cohort_1	75	Female	malignant	III	2454	0.75777	1.6769172538968924	0.8267242778482622	0.9843262324850253	0.5802287666503778	United Kingdom	1
476	Cohort_1	83	Male	malignant	III	3435	1.14231	1.4206076341198304	1.3584333164192541	0.4900443273910744	1.1052757596900902	United Kingdom	1
478	Cohort_1	54	Female	malignant	III	399	1.27803	0.9931392020254023	-0.7726693275436873	-0.00728883861637275	-0.8457899555806421	United Kingdom	1
479	Cohort_1	60	Male	malignant	III	9436	0.53157	0.2452256645057439	1.4631127151185401	-0.18309865025980354	3.4304619635137596	United Kingdom	1
480	Cohort_1	66	Male	malignant	III	5855	2.66916	1.6298948012585655	2.2083481377645704	1.1929804861896907	1.7268108289210478	United Kingdom	1
481	Cohort_1	64	Female	malignant	III	641	0.89349	0.6950042093597707	-0.8140761825292828	-0.036550275794287046	-1.0328986884055835	United Kingdom	1
483	Cohort_1	57	Male	malignant	III	3985	0.81432	-2.3298173568379625	1.7737700856276604	-0.763038120912471	1.3380451776829396	United Kingdom	1
486	Cohort_1	64	Male	malignant	III	69.75	2.83881	1.579369162147482	2.134491504094399	1.2905356961364491	2.0036729352485443	United Kingdom	1
487	Cohort_1	61	Male	malignant	III	783.2	0.36192	0.6904305788820978	0.5850548730298986	-2.235985631570335	0.220684503661432	United Kingdom	1
488	Cohort_1	67	Male	malignant	III	644.8	0.81432	0.8722607870090718	2.6008813657839873	-3.3014854044173787	1.9126619117510248	United Kingdom	1
491	Cohort_1	68	Male	malignant	III	1318	2.1489	-1.1496244991802935	-0.4063670180311254	-0.5852290514652934	-0.13152894625131406	United Kingdom	1
492	Cohort_1	71	Male	malignant	III	3.04	0.66729	0.9405799700240364	1.4399302084704564	-0.2590560869255061	1.177105713965525	United Kingdom	0
493	Cohort_1	78	Male	malignant	III	305.9	1.67388	1.4324611481784526	2.1969898822466147	-0.5502492049029266	1.9990327494270472	United Kingdom	1
494	Cohort_1	82	Male	malignant	III	16.92	0.31668	-0.7217338453402466	-1.0628250922597635	-10.354587466252081	-1.55012920923412	United Kingdom	0
521	Cohort_1	75	Male	malignant	III	1485	0.99528	1.2392290997562974	2.2355581851284407	1.5089107322263144	1.8466012896946271	United Kingdom	1
523	Cohort_1	60	Female	malignant	III	147.7	0.20358	0.41909051802357233	0.13867769054979373	-0.6874910969449637	2.23005422535232	United Kingdom	1
532	Cohort_1	48	Female	malignant	III	1555	0.26013	-1.3782009050961328	-3.5561042741172537	-2.9654613010483883	-0.47562630639457204	United Kingdom	1
536	Cohort_1	60	Male	malignant	III	2204	1.60602	-0.14558075144526117	1.6624688660128752	1.28558631031565	3.4691101684931622	United Kingdom	1
542	Cohort_1	56	Male	malignant	III	57	0.35061	0.40324571439190937	1.5699138922505966	-10.252804771942138	2.9116681700985927	United Kingdom	1
550	Cohort_1	50	Male	malignant	III	885	0.9048	-0.5900476338120888	-0.13335824572404942	-3.9271510763174846	1.7797059017489278	United Kingdom	1
562	Cohort_1	29	Male	malignant	III	468.3	2.80488	0.6858359341604922	2.7650411345116996	1.0459701067740053	1.9577191837965406	United Kingdom	1
563	Cohort_1	53	Male	malignant	III	18360	0.64467	0.9635172542021161	0.6438104642256324	-0.5793787189966819	0.3582985084232462	United Kingdom	1
565	Cohort_1	63	Female	malignant	III	433	0.29406	0.2124709936530561	1.205693568025631	-0.8805896379866791	0.8311780788827798	United Kingdom	1
568	Cohort_1	72	Female	malignant	III	14.67	0.16965	-0.28625834906322656	-2.541144300248728	-3.03909310927583	-2.6525436848312873	United Kingdom	0
569	Cohort_1	75	Female	malignant	III	2202	1.59471	1.3181217122188271	2.269168569762205	0.8310029694840129	1.883547149759976	United Kingdom	1
570	Cohort_1	73	Male	malignant	III	1916	1.31196	0.8273124927441923	1.8854212738778697	0.9020000941781872	0.306203437770856	United Kingdom	1
571	Cohort_1	53	Female	malignant	III	633	2.00187	0.8949337553770315	-0.9328533500795837	-0.4476555926217056	-0.6389461134183101	United Kingdom	1
574	Cohort_1	80	Female	malignant	III	84	0.93873	0.6804404768579998	1.3927389162574633	1.4831334834563323	0.9728841696255284	United Kingdom	1
576	Cohort_1	47	Female	malignant	III	99.6	2.32986	-0.23891047059024384	-1.8883471432835783	-0.15308991292020746	-1.4937007892149001	United Kingdom	1
484	Cohort_1	44	Female	malignant	IV	271.7	2.42034	1.2471417589820804	0.9186706773250961	1.3035429385083592	0.6963812462986931	United Kingdom	1
495	Cohort_1	58	Male	malignant	IV	710.8	0.19227	0.1662000700280445	-0.5647620393809456	-1.371947063842259	-0.3544827172854319	United Kingdom	1
519	Cohort_1	78	Female	malignant	IV	941	0.46371	-0.9072858590036144	-1.3932097486526303	-0.862503736296155	0.8652744824649563	United Kingdom	1
529	Cohort_1	61	Female	malignant	IV	13740	0.32799	0.7042185817376659	0.7550755691386692	-0.025873135590507523	2.1487420949307303	United Kingdom	1
590	Cohort_1	74	Male	malignant	IV	1488	1.50423	1.1535752230701202	1.962913632805484	0.9578290403603633	3.882447087256817	United Kingdom	1
26	Cohort_1	51	Male	control	NA	6.94	0.19227	-0.3794951536443727	-0.9587488873590453	33.07545356471937	-5.6055250213176455	United Kingdom	0
31	Cohort_1	49	Male	control	NA	7.86	0.32799	-0.9387470436443728	1.9506751126409547	-1.0162375352806317	-5.6055250213176455	United Kingdom	0
34	Cohort_1	46	Male	control	NA	6.58	0.35061	-0.9492733136443727	-1.8669408873590454	26.54016246471937	-5.6055250213176455	United Kingdom	0
75	Cohort_1	28	Female	control	NA	84.3	0.32799	-0.9493637936443727	3.462063112640955	12.557107464719369	-5.6055250213176455	United Kingdom	1
252	Cohort_1	48	Male	benign	NA	46.1	0.76908	-0.6897722536443727	0.586818012640955	62.661522464719376	-5.6055250213176455	United Kingdom	1
281	Cohort_1	62	Male	benign	NA	30	0.09048	-0.9503138336443727	-0.9279598873590453	-0.3919475352806314	-5.6055250213176455	United Kingdom	0
533	Cohort_1	68	Male	malignant	III	422	0.28275	0.7560992463556272	-1.425851387359045	18.443244864719368	-5.6055250213176455	United Kingdom	1
100	Cohort_2	51	Male	control	NA	7	0.78039	0.1455889	102.366	461.141	NA	United Kingdom	0
101	Cohort_2	61	Male	control	NA	8	0.70122	0.00280488	60.579	142.95	NA	United Kingdom	0
102	Cohort_2	62	Male	control	NA	9	0.21489	8.5956e-4	65.54	41.088	NA	United Kingdom	0
103	Cohort_2	53	Male	control	NA	NA	0.84825	0.003393	62.126	59.793	NA	United Kingdom	NA
104	Cohort_2	70	Male	control	NA	NA	0.62205	0.1743808	152.277	117.516	NA	United Kingdom	NA
105	Cohort_2	58	Female	control	NA	11	0.89349	0.00357396	3.73	40.294	NA	United Kingdom	0
106	Cohort_2	59	Female	control	NA	NA	0.48633	0.00194532	7.021	26.782	NA	United Kingdom	NA
107	Cohort_2	56	Female	control	NA	24	0.61074	0.2787785	83.928	19.185	NA	United Kingdom	0
108	Cohort_2	77	Female	control	NA	NA	0.29406	0.00117624	6.218	28.297	NA	United Kingdom	NA
109	Cohort_2	71	Male	control	NA	23	1.05183	0.8603368	243.082	608.284	NA	United Kingdom	0
110	Cohort_2	53	Male	control	NA	7	1.91139	1.516773	150.89	590.686	NA	United Kingdom	0
111	Cohort_2	56	Female	control	NA	12	0.91611	0.5996449	93.811	93.576	NA	United Kingdom	0
112	Cohort_2	60	Female	control	NA	28	0.50895	0.0020358	24.366	19.698	NA	United Kingdom	0
113	Cohort_2	69	Female	control	NA	9	0.41847	0.00167388	17.102	0.03264066	NA	United Kingdom	0
114	Cohort_2	60	Female	control	NA	47	0.80301	0.00321204	3.588	30.071	NA	United Kingdom	1
115	Cohort_2	55	Male	control	NA	17	1.28934	2.285351	67.468	269.805	NA	United Kingdom	0
119	Cohort_1	40	Male	control	NA	NA	0.76908	0.6539844	14.607579	341.2674531	NA	United Kingdom	NA
126	Cohort_2	48	Female	control	NA	NA	0.72384	0.00289536	5.354	43.343	NA	United Kingdom	NA
127	Cohort_2	44	Female	control	NA	NA	1.22148	5.309197	21.965	971.553	NA	United Kingdom	NA
128	Cohort_2	44	Female	control	NA	NA	1.17624	4.239308	7.62	436.361	NA	United Kingdom	NA
129	Cohort_2	56	Female	control	NA	NA	0.13572	5.4288e-4	2.276	0.01058616	NA	United Kingdom	NA
130	Cohort_2	44	Female	control	NA	NA	2.02449	6.925281	53.11	1274.49	NA	United Kingdom	NA
131	Cohort_2	48	Female	control	NA	NA	0.15834	6.3336e-4	1.21	3.526	NA	United Kingdom	NA
132	Cohort_2	48	Female	control	NA	NA	0.3393	0.0013572	1.907	3.044	NA	United Kingdom	NA
133	Cohort_2	41	Female	control	NA	NA	0.10179	1.013824	2.795	1.82	NA	United Kingdom	NA
134	Cohort_2	45	Female	control	NA	NA	0.85956	0.963804	29.522	363.076	NA	United Kingdom	NA
135	Cohort_2	45	Female	control	NA	NA	0.59943	4.090239	15.328	67.711	NA	United Kingdom	NA
136	Cohort_2	45	Female	control	NA	NA	0.58812	0.462653	3.612	34.237	NA	United Kingdom	NA
137	Cohort_2	48	Female	control	NA	NA	1.05183	7.300192	118.325	1424.961	NA	United Kingdom	NA
138	Cohort_2	89	Female	control	NA	NA	0.64467	6.836843	76.834	981.545	NA	United Kingdom	NA
139	Cohort_2	87	Male	control	NA	0.05647592	0.06786	2.7144e-4	0.7303665	0.00529308	NA	United Kingdom	0
140	Cohort_2	66	Female	control	NA	4.060258	0.75777	0.008919911	5.41987	8.919911	NA	United Kingdom	0
141	Cohort_2	59	Male	control	NA	0.908578	1.91139	0.06216421	50.1122	62.16421	NA	United Kingdom	0
142	Cohort_2	59	Male	control	NA	3.389304	1.26672	0.007113679	5.22589	7.113679	NA	United Kingdom	0
143	Cohort_2	36	Female	control	NA	5.128234	0.96135	0.01942577	47.254685	19.42577	NA	United Kingdom	0
144	Cohort_2	70	Female	control	NA	1.1359264	0.39585	0.01278068	10.887465	12.78068	NA	United Kingdom	0
145	Cohort_2	63	Female	control	NA	1.9389494	0.42978	0.00171912	5.799405	0.03352284	NA	United Kingdom	0
146	Cohort_2	63	Female	control	NA	2.059078	0.32799	0.00131196	219.8605	0.02558322	NA	United Kingdom	0
147	Cohort_2	59	Male	control	NA	0.5161092	0.88218	0.008404655	8.23218	8.404655	NA	United Kingdom	0
148	Cohort_2	67	Female	control	NA	1.8477128	0.38454	0.001682586	15.06118	1.682586	NA	United Kingdom	0
149	Cohort_2	49	Male	control	NA	2.11638	0.91611	0.01329349	78.4703	13.29349	NA	United Kingdom	0
150	Cohort_2	47	Male	control	NA	2.558004	1.23279	0.04893169	146.7188	48.93169	NA	United Kingdom	0
151	Cohort_2	60	Female	control	NA	6.275096	0.13572	6.47148e-4	3.0346865	0.6471484	NA	United Kingdom	0
152	Cohort_2	60	Female	control	NA	2.370806	0.09048	0.007113679	4.4540935	7.113679	NA	United Kingdom	0
153	Cohort_2	73	Female	control	NA	5.517202	0.20358	8.1432e-4	2.76052	0.01587924	NA	United Kingdom	0
154	Cohort_2	83	Female	control	NA	1.1303358	0.31668	0.00126672	23.192925	0.02470104	NA	United Kingdom	0
155	Cohort_2	60	Female	control	NA	6.223082	0.1131	0.00478765	3.6021425	4.78765	NA	United Kingdom	0
156	Cohort_2	44	Female	control	NA	0.916032	0.12441	0.01764217	13.10085	17.64217	NA	United Kingdom	0
157	Cohort_2	55	Female	control	NA	0.749904	0.4524	6.47148e-4	6.85593	0.6471484	NA	United Kingdom	0
158	Cohort_2	51	Female	control	NA	1.0800212	0.2262	9.048e-4	5.30383	0.0176436	NA	United Kingdom	0
159	Cohort_2	56	Female	control	NA	1.9369218	0.16965	6.786e-4	0.9549	0.0132327	NA	United Kingdom	0
160	Cohort_2	65	Female	control	NA	2.52441	0.70122	0.02898082	60.37345	28.98082	NA	United Kingdom	0
161	Cohort_2	45	Male	control	NA	2.532164	0.37323	0.00149292	12.953345	0.02911194	NA	United Kingdom	0
162	Cohort_2	64	Female	control	NA	0.4571338	0.12441	4.9764e-4	6.53329	0.00970398	NA	United Kingdom	0
163	Cohort_2	26	Female	control	NA	3.527344	0.19227	9.06008e-4	13.02703	0.9060078	NA	United Kingdom	0
164	Cohort_2	34	Female	control	NA	0.8135388	0.53157	0.008662283	7.88036	8.662283	NA	United Kingdom	0
165	Cohort_2	45	Female	control	NA	0.05156496	0.06786	0.01046568	3.222564	10.46568	NA	United Kingdom	0
166	Cohort_2	51	Female	control	NA	0.8303104	0.14703	3.88289e-4	87.5727	0.3882891	NA	United Kingdom	0
167	Cohort_2	67	Female	control	NA	0.7140976	1.09707	0.002976883	14.600835	2.976883	NA	United Kingdom	0
168	Cohort_2	64	Female	control	NA	6.159064	0.4524	9.06008e-4	2.896185	0.9060078	NA	United Kingdom	0
169	Cohort_2	50	Female	control	NA	0	0.53157	0.005046098	5.381445	5.046098	NA	United Kingdom	0
170	Cohort_2	63	Female	control	NA	0.5140028	0.30537	0.005304546	7.56369	5.304546	NA	United Kingdom	0
171	Cohort_2	81	Female	control	NA	25.38502	1.02921	0.003494602	1.6164935	3.494602	NA	United Kingdom	0
172	Cohort_2	71	Male	control	NA	1.9835538	0.14703	1.2943e-4	6.424855	0.1294297	NA	United Kingdom	0
173	Cohort_2	71	Female	control	NA	0.7309476	0.3393	0.003753461	4.948546	3.753461	NA	United Kingdom	0
174	Cohort_2	35	Female	control	NA	0.6488036	0.41847	0.01636817	31.913445	16.36817	NA	United Kingdom	0
175	Cohort_2	57	Female	control	NA	5.025272	0.29406	6.47148e-4	8.23218	0.6471484	NA	United Kingdom	0
176	Cohort_2	64	Male	control	NA	1.2861902	1.06314	0.0237283	27.022365	23.7283	NA	United Kingdom	0
177	Cohort_2	40	Male	control	NA	3.95146	0.27144	1.2943e-4	7.24631	0.1294297	NA	United Kingdom	0
178	Cohort_2	46	Male	control	NA	0.8023578	1.67388	0.007113679	115.367	7.113679	NA	United Kingdom	0
179	Cohort_2	61	Female	control	NA	5.151994	0.76908	0.00307632	8.654645	0.05998824	NA	United Kingdom	0
180	Cohort_2	71	Female	control	NA	1.1787872	0.26013	1.2943e-4	5.22589	0.1294297	NA	United Kingdom	0
181	Cohort_2	38	Female	control	NA	0.13996204	0.30537	0.00122148	9.57219	0.02381886	NA	United Kingdom	0
182	Cohort_2	50	Male	control	NA	1.2029986	1.131	0.004524	49.35476	0.088218	NA	United Kingdom	0
183	Cohort_2	84	Female	control	NA	4.744934	0.49764	0.00199056	17.994015	0.03881592	NA	United Kingdom	0
23	Cohort_2	50	Female	control	NA	NA	0.63336	0.00253344	45.294	95.767	NA	United Kingdom	NA
3	Cohort_2	49	Female	control	NA	NA	1.49292	0.9241479	18.826	124.278	NA	United Kingdom	NA
4	Cohort_2	37	Male	control	NA	NA	0.71253	0.00285012	0.001104422	39.056	NA	United Kingdom	NA
62	Cohort_2	43	Female	control	NA	NA	0.28275	0.001131	15.28	0.0220545	NA	United Kingdom	NA
64	Cohort_1	48	Female	control	NA	NA	3.44955	4.512589	138.79873	1876.588322	NA	United Kingdom	NA
65	Cohort_2	41	Female	control	NA	NA	0.57681	0.00230724	8.075	26.138	NA	United Kingdom	NA
74	Cohort_2	69	Female	control	NA	9	1.17624	0.901411	44.535	330.166	NA	United Kingdom	0
78	Cohort_2	43	Male	control	NA	NA	0.97266	0.4069507	35.689	254.224	NA	United Kingdom	NA
79	Cohort_2	30	Female	control	NA	NA	1.71912	1.642057	43.827	326.372	NA	United Kingdom	NA
80	Cohort_2	58	Male	control	NA	NA	0.88218	1.155294	26.996	654.165	NA	United Kingdom	NA
81	Cohort_2	50	Male	control	NA	NA	1.31196	0.874513	21.96	199.71	NA	United Kingdom	NA
82	Cohort_2	55	Male	control	NA	NA	0.20358	8.1432e-4	2.45	6.192	NA	United Kingdom	NA
83	Cohort_2	59	Female	control	NA	NA	0.6786	0.512019	4.973	69.934	NA	United Kingdom	NA
84	Cohort_2	66	Female	control	NA	28	0.47502	0.00190008	98.933	70.108	NA	United Kingdom	0
85	Cohort_2	62	Female	control	NA	NA	0.13572	0.15187	31.452	31.25	NA	United Kingdom	NA
86	Cohort_2	72	Female	control	NA	NA	0.32799	0.4069507	125.125	158.943	NA	United Kingdom	NA
87	Cohort_2	63	Male	control	NA	11	1.02921	0.6972028	47.066	170.594	NA	United Kingdom	0
88	Cohort_2	65	Male	control	NA	NA	0.20358	8.1432e-4	32.923	70.35	NA	United Kingdom	NA
89	Cohort_2	68	Female	control	NA	NA	0.07917	3.1668e-4	6.122	19.185	NA	United Kingdom	NA
90	Cohort_2	59	Male	control	NA	NA	1.50423	0.109682	4.197	45.353	NA	United Kingdom	NA
91	Cohort_2	53	Female	control	NA	NA	0.07917	3.1668e-4	33.995	23.867	NA	United Kingdom	NA
92	Cohort_2	73	Female	control	NA	7	0.14703	5.8812e-4	14.024	16.64	NA	United Kingdom	0
93	Cohort_2	54	Female	control	NA	NA	0.2262	9.048e-4	26.96	22.289	NA	United Kingdom	NA
94	Cohort_2	63	Female	control	NA	NA	0.57681	0.1311966	38.715	35.871	NA	United Kingdom	NA
95	Cohort_2	66	Female	control	NA	4	0.3393	0.0013572	9.297	33.307	NA	United Kingdom	0
96	Cohort_2	65	Female	control	NA	34	1.2441	0.2289	17.199	273.424	NA	United Kingdom	0
97	Cohort_2	69	Female	control	NA	NA	0.87087	0.00348348	80.338	22.289	NA	United Kingdom	NA
98	Cohort_2	62	Female	control	NA	3	0.31668	0.1096826	68.926	36.59	NA	United Kingdom	0
99	Cohort_2	76	Female	control	NA	8	0.5655	0.002262	24.317	62.488	NA	United Kingdom	0
271	Cohort_2	32	Female	benign	NA	12	1.16493	5.417692	21.135	445.725	NA	United Kingdom	0
299	Cohort_2	59	Female	benign	NA	NA	0.41847	0.526248	24.111	4.09	NA	United Kingdom	NA
308	Cohort_2	65	Female	benign	NA	NA	0.36192	2.343091	12.957	0.02822976	NA	United Kingdom	NA
314	Cohort_2	39	Female	benign	NA	NA	0.89349	0.736352	21.55	105.943	NA	United Kingdom	NA
315	Cohort_2	65	Female	benign	NA	13	0.37323	0.228904	13.977	7.367	NA	United Kingdom	0
344	Cohort_2	59	Male	benign	NA	49	0.74646	4.9695	59.362	489.465	NA	United Kingdom	1
329	Cohort_2	61	Female	benign	NA	NA	0.3393	0.1361	20.006	41.578	NA	United Kingdom	NA
260	Cohort_2	55	Female	benign	NA	NA	0.6786	0.604511	11.941	72.624	NA	United Kingdom	NA
261	Cohort_2	74	Female	benign	NA	NA	0.75777	0.222569	18.828	133.222	NA	United Kingdom	NA
263	Cohort_2	71	Female	benign	NA	NA	1.36851	0.7286653	14.704	200.093	NA	United Kingdom	NA
274	Cohort_2	52	Female	benign	NA	NA	0.19227	0.12713	36.126	7.562	NA	United Kingdom	NA
275	Cohort_2	37	Female	benign	NA	9	0.97266	3.669337	45.618	179.403	NA	United Kingdom	0
280	Cohort_2	41	Female	benign	NA	NA	1.16493	0.718782	4.919	8.043	NA	United Kingdom	NA
282	Cohort_2	60	Female	benign	NA	NA	0.57681	0.00230724	1.268	0.04499118	NA	United Kingdom	NA
321	Cohort_2	46	Male	benign	NA	11	0.61074	0.6134921	59.099	8.043	NA	United Kingdom	0
323	Cohort_2	29	Female	benign	NA	NA	0.12441	4.9764e-4	0.201	11.541	NA	United Kingdom	NA
363	Cohort_2	60	Female	benign	NA	8	1.52685	1.446104	42.94	949.133	NA	United Kingdom	0
365	Cohort_2	26	Female	benign	NA	26	0.23751	9.5004e-4	3.68	50.945	NA	United Kingdom	0
371	Cohort_2	52	Female	benign	NA	NA	0.3393	1.473988	182.152	853.015	NA	United Kingdom	NA
361	Cohort_2	78	Male	benign	NA	NA	0.82563	4.51414	80.158	763.903	NA	United Kingdom	NA
362	Cohort_2	28	Female	benign	NA	5	0.44109	0.00176436	10.888	18.613	NA	United Kingdom	0
364	Cohort_2	50	Female	benign	NA	29	0.92742	1.555825	32.086	191.499	NA	United Kingdom	0
272	Cohort_2	38	Female	benign	NA	15	0.16965	0.209901	18.351	0.0132327	NA	United Kingdom	0
246	Cohort_2	68	Male	benign	NA	11	0.76908	4.885849	143.51	780.348	NA	United Kingdom	0
257	Cohort_2	36	Female	benign	NA	17	0.16965	0.480592	19.861	10.06	NA	United Kingdom	0
316	Cohort_2	54	Male	benign	NA	14	1.05183	0.00420732	10.958	9.51	NA	United Kingdom	0
347	Cohort_2	73	Male	benign	NA	9	1.131	4.860454	704.236	3283.593	NA	United Kingdom	0
350	Cohort_2	82	Female	benign	NA	NA	0.57681	2.169731	43.278	60.48	NA	United Kingdom	NA
278	Cohort_2	72	Female	benign	NA	NA	1.51554	1.234861	42.507	674.289	NA	United Kingdom	NA
320	Cohort_2	54	Female	benign	NA	NA	1.39113	1.210892	58.965	663.823	NA	United Kingdom	NA
370	Cohort_2	62	Male	benign	NA	NA	0.38454	0.2471	1.404	0.02999412	NA	United Kingdom	NA
279	Cohort_2	36	Female	benign	NA	15	0.9048	0.444877	40.416	651.513	NA	United Kingdom	0
298	Cohort_2	31	Male	benign	NA	NA	0.73515	0.0029406	12.643	94.847	NA	United Kingdom	NA
296	Cohort_2	68	Male	benign	NA	NA	0.40716	0.00162864	1.39	6.192	NA	United Kingdom	NA
290	Cohort_2	54	Male	benign	NA	NA	0.71253	2.331806	24.144	136.847	NA	United Kingdom	NA
292	Cohort_2	43	Female	benign	NA	9	0.38454	0.00153816	2.45	11.864	NA	United Kingdom	0
293	Cohort_2	56	Female	benign	NA	5	0.4524	1.161454	10.27	80.775	NA	United Kingdom	0
306	Cohort_2	75	Male	benign	NA	NA	0.46371	1.463971	11.712	3.239	NA	United Kingdom	NA
309	Cohort_2	55	Female	benign	NA	NA	0.10179	4.0716e-4	1.51	4.09	NA	United Kingdom	NA
310	Cohort_2	41	Male	benign	NA	NA	1.32327	1.897387	29.548	46.814	NA	United Kingdom	NA
311	Cohort_2	40	Female	benign	NA	NA	0.07917	3.1668e-4	1.214	1.341	NA	United Kingdom	NA
312	Cohort_2	46	Female	benign	NA	6	0.91611	2.548646	28.145	37.51	NA	United Kingdom	0
313	Cohort_2	37	Female	benign	NA	NA	0.66729	0.00266916	1.446	153.769	NA	United Kingdom	NA
327	Cohort_2	41	Male	benign	NA	NA	1.39113	1.657666	39.319	364.986	NA	United Kingdom	NA
328	Cohort_2	62	Male	benign	NA	NA	2.75964	5.8835	201.015	1538.683	NA	United Kingdom	NA
333	Cohort_2	40	Male	benign	NA	NA	1.60602	0.318729	19.703	189.889	NA	United Kingdom	NA
336	Cohort_2	49	Female	benign	NA	7	0.80301	0.00321204	36.354	89.238	NA	United Kingdom	0
339	Cohort_2	68	Male	benign	NA	8	0.9048	1.006566	11.138	0.0705744	NA	United Kingdom	0
341	Cohort_2	69	Female	benign	NA	NA	0.27144	0.00108576	3.861	6.698	NA	United Kingdom	NA
342	Cohort_2	65	Male	benign	NA	NA	0.35061	2.828798	28.639	82.318	NA	United Kingdom	NA
343	Cohort_2	66	Female	benign	NA	NA	1.8096	0.0072384	0.00280488	88.496	NA	United Kingdom	NA
353	Cohort_2	48	Male	benign	NA	NA	1.40244	6.436525	24.187	668.208	NA	United Kingdom	NA
354	Cohort_2	41	Male	benign	NA	NA	0.87087	1.309005	101.887	237.143	NA	United Kingdom	NA
355	Cohort_2	38	Female	benign	NA	NA	0.74646	0.512019	2.922	95.053	NA	United Kingdom	NA
250	Cohort_2	65	Female	benign	NA	17	0.06786	1.415519	101.435	110.68	NA	United Kingdom	0
269	Cohort_2	49	Female	benign	NA	NA	2.1489	0.109038	8.246	169.544	NA	United Kingdom	NA
346	Cohort_2	75	Male	benign	NA	NA	0.35061	1.470872	70.652	141.907	NA	United Kingdom	NA
351	Cohort_2	52	Female	benign	NA	42	0.14703	5.8812e-4	13.78	27.661	NA	United Kingdom	1
352	Cohort_2	53	Female	benign	NA	NA	0.15834	0.197232	8.659	78.13	NA	United Kingdom	NA
245	Cohort_2	53	Male	benign	NA	25	1.3572	4.115126	99.147	425.39	NA	United Kingdom	0
357	Cohort_2	40	Male	benign	NA	NA	1.0179	1.498139	11.118	84.65	NA	United Kingdom	NA
273	Cohort_2	77	Female	benign	NA	37	1.41375	1.035598	90.681	565.79	NA	United Kingdom	0
265	Cohort_2	70	Female	benign	NA	19	0.78039	6.018273	19.017	566.488	NA	United Kingdom	0
331	Cohort_2	79	Male	benign	NA	NA	0.80301	5.353564	21.389	423.328	NA	United Kingdom	NA
285	Cohort_2	52	Female	benign	NA	14	0.89349	0.2109439	54.483	140.046	NA	United Kingdom	0
340	Cohort_2	45	Male	benign	NA	17	1.34589	2.641155	188.913	813.874	NA	United Kingdom	0
303	Cohort_2	52	Female	benign	NA	NA	0.78039	1.076629	5.797	181.46	NA	United Kingdom	NA
319	Cohort_2	29	Female	benign	NA	25	1.131	3.565135	240.235	671.283	NA	United Kingdom	0
238	Cohort_2	42	Male	benign	NA	116	0.31668	0.3040158	11.457	672.536	NA	United Kingdom	1
295	Cohort_2	45	Male	benign	NA	NA	1.10838	1.231025	114.815	806.238	NA	United Kingdom	NA
234	Cohort_2	40	Female	benign	NA	20	0.16965	1.82949	6.586	809.637	NA	United Kingdom	0
251	Cohort_2	40	Male	benign	NA	21	0.62205	1.492887	229.629	463.463	NA	United Kingdom	0
256	Cohort_2	57	Female	benign	NA	NA	0.37323	0.00149292	3.223	0.02911194	NA	United Kingdom	NA
262	Cohort_2	69	Male	benign	NA	NA	0.75777	0.1647787	85.345	496.849	NA	United Kingdom	NA
264	Cohort_1	57	Male	benign	NA	12.8	0.42978	0.00171912	12.949153	0.03352284	NA	United Kingdom	0
267	Cohort_2	47	Male	benign	NA	18	0.30537	0.00122148	8.815	96.333	NA	United Kingdom	0
325	Cohort_2	42	Male	benign	NA	NA	0.20358	8.1432e-4	2.222	16.276	NA	United Kingdom	NA
358	Cohort_2	57	Male	benign	NA	112	1.04052	4.077191	14.276	480.118	NA	United Kingdom	1
243	Cohort_2	65	Male	benign	NA	21	0.59943	3.488079	479.944	516.538	NA	United Kingdom	0
284	Cohort_2	78	Male	benign	NA	NA	1.02921	1.777817	465.267	2962.862	NA	United Kingdom	NA
242	Cohort_2	61	Female	benign	NA	10	0.20358	0.6800993	54.456	159.966	NA	United Kingdom	0
334	Cohort_2	54	Male	benign	NA	NA	0.1131	0.2109439	248.426	273.859	NA	United Kingdom	NA
232	Cohort_2	66	Male	benign	NA	NA	0.74646	0.00298584	20.304	113.906	NA	United Kingdom	NA
241	Cohort_2	69	Female	benign	NA	10	0.05655	2.262e-4	5.112	200.165	NA	United Kingdom	0
258	Cohort_2	55	Female	benign	NA	NA	0.27144	0.7972104	245.867	356.337	NA	United Kingdom	NA
304	Cohort_2	58	Male	benign	NA	NA	0.87087	1.446104	551.971	1589.895	NA	United Kingdom	NA
231	Cohort_1	71	Male	benign	NA	NA	0.84825	4.205964	53.650114	454.8348	NA	United Kingdom	NA
322	Cohort_2	42	Male	benign	NA	9	0.35061	0.1042893	6.133	107.993	NA	United Kingdom	0
305	Cohort_2	56	Male	benign	NA	4	0.66729	0.9406302	19.427	137.165	NA	United Kingdom	0
237	Cohort_2	46	Male	benign	NA	1	0.89349	0.00357396	15.753	459.471	NA	United Kingdom	0
240	Cohort_2	52	Female	benign	NA	41	0.3393	0.0013572	0.293	73.736	NA	United Kingdom	1
317	Cohort_2	80	Male	benign	NA	NA	0.3393	1.250582	3.294	48.497	NA	United Kingdom	NA
345	Cohort_2	70	Male	benign	NA	NA	1.07445	1.657666	6.615	107.213	NA	United Kingdom	NA
326	Cohort_2	58	Male	benign	NA	1	0.82563	0.00330252	5.519	83.18	NA	United Kingdom	0
248	Cohort_2	48	Male	benign	NA	4	1.60602	0.2948	64.311	665.848	NA	United Kingdom	0
253	Cohort_2	66	Female	benign	NA	16	1.16493	4.782489	71.785	466.404	NA	United Kingdom	0
324	Cohort_2	41	Female	benign	NA	NA	0.75777	6.239161	323.441	675.497	NA	United Kingdom	NA
291	Cohort_2	53	Male	benign	NA	NA	0.36192	0.00144768	3.396	76.028	NA	United Kingdom	NA
301	Cohort_2	38	Female	benign	NA	NA	0.41847	4.040424	7.427	55.019	NA	United Kingdom	NA
332	Cohort_2	29	Male	benign	NA	13	0.21489	3.719767	12.739	122.842	NA	United Kingdom	0
287	Cohort_2	58	Female	benign	NA	10	0.31668	0.8427024	29.205	65.73	NA	United Kingdom	0
297	Cohort_2	77	Female	benign	NA	NA	0.1131	0.04228796	24.707	14.756	NA	United Kingdom	NA
277	Cohort_2	67	Female	benign	NA	11	0.80301	0.00321204	3.751	336.579	NA	United Kingdom	0
268	Cohort_2	47	Female	benign	NA	20	0.39585	0.0015834	10.786	112.488	NA	United Kingdom	0
270	Cohort_2	50	Female	benign	NA	3	0.23751	9.5004e-4	1.234	2.675	NA	United Kingdom	0
359	Cohort_2	44	Female	benign	NA	NA	0.87087	1.365322	41.283	250.708	NA	United Kingdom	NA
255	Cohort_2	66	Male	benign	NA	52	0.37323	0.5924902	19.716	207.646	NA	United Kingdom	1
289	Cohort_2	52	Male	benign	NA	NA	0.09048	3.6192e-4	4.912	5.615	NA	United Kingdom	NA
235	Cohort_2	72	Male	benign	NA	26	0.65598	0.2552534	8.212	204.173	NA	United Kingdom	0
276	Cohort_2	59	Female	benign	NA	6	0.3393	1.115925	21.772	74.864	NA	United Kingdom	0
236	Cohort_2	76	Female	benign	NA	27	0.83694	6.482307	193.916	744.757	NA	United Kingdom	0
247	Cohort_2	40	Female	benign	NA	28	0.31668	0.00126672	2.634	73.684	NA	United Kingdom	0
266	Cohort_2	47	Female	benign	NA	14	0.20358	8.1432e-4	9.728	0.01587924	NA	United Kingdom	0
283	Cohort_2	64	Female	benign	NA	NA	1.2441	3.497074	188.642	962.636	NA	United Kingdom	NA
330	Cohort_2	46	Female	benign	NA	39	0.57681	0.1204693	3.803	0.04499118	NA	United Kingdom	1
335	Cohort_2	75	Female	benign	NA	7	0.54288	3.841183	147.268	146.76	NA	United Kingdom	0
360	Cohort_2	49	Female	benign	NA	20	0.71253	0.6324326	22.602	494.588	NA	United Kingdom	0
259	Cohort_2	53	Female	benign	NA	21	0.4524	0.963804	21.32	78.292	NA	United Kingdom	0
300	Cohort_2	74	Female	benign	NA	13	0.12441	4.9764e-4	1.295	42.667	NA	United Kingdom	0
302	Cohort_2	69	Male	benign	NA	NA	0.13572	5.4288e-4	19.427	2.578	NA	United Kingdom	NA
288	Cohort_2	63	Female	benign	NA	NA	0.58812	0.928816	29.334	1.877	NA	United Kingdom	NA
497	Cohort_1	81	Female	malignant	I	NA	0.5655	12.017150000000001	431.42253	874.0997	NA	Spain	NA
573	Cohort_2	58	Male	malignant	IA	11	0.44109	0.6324326	188.253	138.63	NA	United Kingdom	0
577	Cohort_2	67	Male	malignant	IB	5335	0.49764	1.783212	112.348	47.851	NA	United Kingdom	1
584	Cohort_2	75	Male	malignant	IB	NA	0.71253	1.619339	8.675667	610.8991	NA	United Kingdom	NA
585	Cohort_2	74	Female	malignant	IB	NA	0.13572	1.920327	219.129024	414.6139	NA	United Kingdom	NA
586	Cohort_2	77	Male	malignant	IB	NA	0.15834	0.5658398	321.30816	1068.504	NA	United Kingdom	NA
587	Cohort_2	63	Female	malignant	IB	NA	0.35061	1.085064	70.60501	1115.292	NA	United Kingdom	NA
588	Cohort_2	60	Female	malignant	IB	NA	0.16965	1.319144	28.068943	102.4494	NA	United Kingdom	NA
589	Cohort_2	52	Female	malignant	IB	NA	1.62864	2.056438	8.432788	433.533	NA	United Kingdom	NA
504	Cohort_1	54	Male	malignant	II	NA	1.05183	10.95695	1293.81945	2921.5071	NA	Spain	NA
508	Cohort_1	66	Male	malignant	II	NA	0.89349	10.25015	279.52484	977.8096	NA	Spain	NA
518	Cohort_1	55	Male	malignant	II	NA	2.23938	11.99636	686.5964	2395.0812	NA	Spain	NA
527	Cohort_2	48	Male	malignant	IIA	6	0.29406	3.530855	1124.108	6939.098	NA	United Kingdom	0
553	Cohort_2	71	Female	malignant	IIA	492	0.99528	1.806422	190.812	736.673	NA	United Kingdom	1
538	Cohort_2	76	Male	malignant	IIB	198	0.18096	1.013392	123.01	929.408	NA	United Kingdom	1
540	Cohort_2	70	Female	malignant	IIB	259	0.10179	4.230177	55.88	45.233	NA	United Kingdom	1
543	Cohort_2	77	Female	malignant	IIB	12	0.72384	9.56575	193.089	844.044	NA	United Kingdom	0
544	Cohort_2	79	Female	malignant	IIB	33	1.51554	11.21034	1215.168	951.085	NA	United Kingdom	0
545	Cohort_2	71	Male	malignant	IIB	434	0.1131	0.7735073	149.629	98.272	NA	United Kingdom	1
546	Cohort_2	77	Female	malignant	IIB	5236	0.18096	7.140791	40.543	196.062	NA	United Kingdom	1
551	Cohort_2	58	Male	malignant	IIB	744	1.06314	1.14499	4.729	155.445	NA	United Kingdom	1
552	Cohort_2	73	Female	malignant	IIB	2203	2.77095	12.794	1037.972	4225.523	NA	United Kingdom	1
554	Cohort_2	68	Female	malignant	IIB	NA	0.62205	6.063309	111.083	437.46	NA	United Kingdom	NA
556	Cohort_2	70	Female	malignant	IIB	NA	0.61074	5.504886	17.621	167.049	NA	United Kingdom	NA
559	Cohort_2	67	Female	malignant	IIB	NA	0.09048	2.95921	29.138	209.676	NA	United Kingdom	NA
561	Cohort_2	53	Female	malignant	IIB	2478	1.2441	5.772537	750.559	2416.474	NA	United Kingdom	1
572	Cohort_2	66	Female	malignant	IIB	936	4.11684	10.73328	1195.972	13344.3	NA	United Kingdom	1
578	Cohort_2	57	Male	malignant	IIB	NA	0.48633	2.828798	208.371	333.852	NA	United Kingdom	NA
579	Cohort_2	82	Male	malignant	IIB	NA	0.46371	6.011376	150.056	263.163	NA	United Kingdom	NA
580	Cohort_2	88	Female	malignant	IIB	NA	1.09707	10.27304	113.094	1256.712	NA	United Kingdom	NA
581	Cohort_2	67	Female	malignant	IIB	NA	0.32799	1.172141	123.27	43.537	NA	United Kingdom	NA
582	Cohort_2	49	Male	malignant	IIB	NA	1.11969	5.778975	71.054	235.618	NA	United Kingdom	NA
505	Cohort_1	62	Male	malignant	III	NA	0.75777	9.325072	246.6702	994.9241	NA	Spain	NA
507	Cohort_1	64	Male	malignant	III	NA	0.49764	6.684962	47.699981	778.4544	NA	Spain	NA
510	Cohort_1	51	Male	malignant	III	NA	2.74833	10.48922	865.2882	1308.224	NA	Spain	NA
511	Cohort_1	86	Male	malignant	III	NA	0.23751	10.62434	712.37586	785.1042	NA	Spain	NA
512	Cohort_1	56	Female	malignant	III	NA	0.59943	8.368812	123.235	1163.021	NA	Spain	NA
515	Cohort_1	59	Male	malignant	III	NA	1.39113	7.797134	145.01662	1118.7687	NA	Spain	NA
516	Cohort_1	64	Female	malignant	III	NA	0.73515	7.183881	44.535232	262.3092	NA	Spain	NA
526	Cohort_1	65	Male	malignant	III	NA	0.27144	3.682237	361.89776	0.02117232	NA	United Kingdom	NA
528	Cohort_1	68	Female	malignant	III	2484	0.26013	7.479967	200.6403	1127.803	NA	United Kingdom	1
555	Cohort_2	47	Male	malignant	III	NA	0.36192	1.764729	15.285	50.56	NA	United Kingdom	NA
566	Cohort_2	75	Male	malignant	III	NA	0.73515	2.72438	183.879	1383.49	NA	United Kingdom	NA
575	Cohort_1	42	Female	malignant	III	19.16	0.4524	0.4877182	111.71032	605.8256	NA	United Kingdom	0
499	Cohort_1	87	Male	malignant	IV	NA	0.71253	10.13581	370.1054	3351.345	NA	Spain	NA
500	Cohort_1	78	Male	malignant	IV	NA	0.66729	6.882451	109.41756	197.8939	NA	Spain	NA
501	Cohort_1	85	Male	malignant	IV	NA	1.25541	9.52256	404.49535	3570.915	NA	Spain	NA
503	Cohort_1	81	Male	malignant	IV	NA	0.78039	10.47882	696.71616	2720.5437	NA	Spain	NA
506	Cohort_1	78	Female	malignant	IV	NA	1.82091	3.629087	119.24325	903.126	NA	Spain	NA
509	Cohort_1	65	Male	malignant	IV	NA	1.86615	8.99246	1403.8976	4320.489	NA	Spain	NA
513	Cohort_1	70	Male	malignant	IV	NA	0.78039	7.859499	34.189659	373.5307	NA	Spain	NA
514	Cohort_1	78	Male	malignant	IV	NA	1.0179	15.27052	132.87988000000001	2333.0889	NA	Spain	NA
535	Cohort_2	58	Female	malignant	IV	NA	2.39772	0.2895	6.824	799.256	NA	United Kingdom	NA
539	Cohort_2	84	Male	malignant	IV	NA	0.66729	5.764349	950.08	1945.172	NA	United Kingdom	NA
548	Cohort_2	66	Male	malignant	IV	NA	0.93873	7.085637	815.136	2367.59	NA	United Kingdom	NA
549	Cohort_2	68	Male	malignant	IV	NA	0.52026	7.058209	156.241	525.178	NA	United Kingdom	NA
558	Cohort_2	71	Female	malignant	IV	NA	0.85956	8.341207	16.915	245.947	NA	United Kingdom	NA
560	Cohort_2	63	Male	malignant	IV	NA	1.36851	7.674707	289.701	537.286	NA	United Kingdom	NA
583	Cohort_2	75	Female	malignant	IV	NA	1.33458	8.206777	205.93	722.523	NA	United Kingdom	NA
